XPH ETF

$54.72

Returns Overview

1 Month
+3.77%
3 Months
+5.14%
6 Months
+21.56%
YTD
+3.91%
1 Year
+30.06%
3 Years
+13.12%
5 Years
+2.79%
10 Years
+4.49%

Risk Metrics (5-Year)

No risk data available for this ETF

Stress Test Scenarios

How would XPH have held up?
🦠COVID-19 Crash33 days
Market peak to trough during pandemic sell-off
Run Analysis
📈2022 Rate Hikes9 months
Fed aggressive rate hiking cycle bear market
🔒Upgrade to run
📉2018 Q4 Selloff3 months
Trade war fears and Fed tightening
🔒Upgrade to run
🏦SVB / Banking Crisis5 days
Regional banking contagion fears
🔒Upgrade to run

1 Month Performance

+3.77%

3 Months Performance

+5.14%

6 Months Performance

+21.56%

1 Year Performance

+30.06%

Benchmark & Peers

Benchmark
S&P Pharmaceuticals Select Industry Index(^SPSIPH:SP)
This ETF (YTD)
+3.91%
Peer Avg (YTD)
+1.55%
vs Peers
+2.36%

XPH ETF Performance

XPH performance across multiple time periods: 1-month 3.77%, YTD 3.91%, 1-year 30.06%, 3-year 13.12%, 5-year 2.79%, 10-year 4.49%.

XPH returns outperform the peer average of 1.55% YTD. With an expense ratio of 0.35%, investors should weigh costs against performance when evaluating this ETF.

XPH performance comparison shows side-by-side returns with another fund. XPH alternatives are available in the ETF Screener.

Performance & Returns

Loading chart...

Performance Returns

PeriodTotal ReturnDate Range
1 Month+3.77%N/A
3 Months+5.14%N/A
6 Months+21.56%N/A
1 Year+30.06%N/A
3 Years+13.12%N/A
5 Years+2.79%N/A

All returns shown are total returns, not annualized